Drug Information

Drug General Information
Drug ID
D02LCC
Former ID
DNC005232
Drug Name
2-(4-Hydroxy-phenyl)-7-isopropyl-benzooxazol-5-ol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527232]
Structure
Download
2D MOL

3D MOL
Formula
C16H15NO3
Canonical SMILES
CC(C)C1=CC(=CC2=C1OC(=C3C=CC(=O)C=C3)N2)O
InChI
1S/C16H15NO3/c1-9(2)13-7-12(19)8-14-15(13)20-16(17-14)10-3-5-11(18)6-4-10/h3-9,17,19H,1-2H3
InChIKey
RMBSHKZYEBWVEE-UHFFFAOYSA-N
PubChem Compound ID
11323162
Target and Pathway
Target(s) Estrogen receptor Target Info Inhibitor [527232]
Estrogen receptor beta Target Info Inhibitor [527232]
KEGG Pathway Estrogen signaling pathway
Prolactin signaling pathway
Thyroid hormone signaling pathway
Endocrine and other factor-regulated calcium reabsorption
Proteoglycans in cancerhsa04915:Estrogen signaling pathway
NetPath Pathway FSH Signaling Pathway
EGFR1 Signaling Pathway
RANKL Signaling Pathway
Pathway Interaction Database Regulation of nuclear SMAD2/3 signaling
Signaling events mediated by HDAC Class II
Plasma membrane estrogen receptor signaling
LKB1 signaling events
Regulation of Telomerase
ATF-2 transcription factor network
AP-1 transcription factor network
FOXM1 transcription factor network
Validated nuclear estrogen receptor alpha network
Signaling mediated by p38-alpha and p38-beta
FOXA1 transcription factor networker_nongenomic_pathway:Plasma membrane estrogen receptor signaling
Validated nuclear estrogen receptor beta network
Reactome Nuclear signaling by ERBB4
Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway
WikiPathways Estrogen signaling pathway
Nuclear Receptors Meta-Pathway
Estrogen Receptor Pathway
Signaling by ERBB4
JAK/STAT
Integrated Pancreatic Cancer Pathway
Leptin signaling pathway
miR-targeted genes in muscle cell - TarBase
Integrated Breast Cancer Pathway
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
Ovarian Infertility Genes
Nuclear Receptors
References
Ref 527232J Med Chem. 2004 Oct 7;47(21):5021-40.Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Ref 527232J Med Chem. 2004 Oct 7;47(21):5021-40.Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.